Clinical trial APT-008APT-008
A First in Human, Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS301984-HSO as Monotherapy and in Combination with Pembrolizumab or Other Anti-Cancer Treatments in Participants with Advanced Solid Tumors (APT-008APT-008)
| Organ | Multiple |
|---|---|
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/1b |
| Academic trial | Non |
| Sponsor | iTeos |
| EudraCT Identifier | 2023-503844-14-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT06547957 |
| Last update |